Fast and high-throughput LC-MS characterization, and peptide mapping of engineered AAV capsids using LC-MS/MS
Open Access
- 24 September 2022
- journal article
- research article
- Published by Elsevier in Molecular Therapy - Methods & Clinical Development
- Vol. 27, 185-194
Abstract
No abstract availableKeywords
Funding Information
- School of Medicine, Indiana University
- National Institutes of Health (1P01HL160472-01, 1U54HL142019-01, 5R01HL130871-02, 5T32HL007910-23)
This publication has 20 references indexed in Scilit:
- Capsid Modifications for Targeting and Improving the Efficacy of AAV VectorsMolecular Therapy - Methods & Clinical Development, 2019
- Oligonucleotide conjugated multi-functional adeno-associated virusesScientific Reports, 2018
- Direct Liquid Chromatography/Mass Spectrometry Analysis for Complete Characterization of Recombinant Adeno-Associated Virus Capsid ProteinsHuman Gene Therapy Methods, 2017
- Site-Specific PEGylated Adeno-Associated Viruses with Increased Serum Stability and Reduced ImmunogenicityMolecules, 2017
- Structure-guided evolution of antigenically distinct adeno-associated virus variants for immune evasionProceedings of the National Academy of Sciences, 2017
- Syngeneic AAV Pseudo-particles Potentiate Gene Transduction of AAV VectorsMolecular Therapy - Methods & Clinical Development, 2017
- A Precise Chemical Strategy To Alter the Receptor Specificity of the Adeno‐Associated VirusAngewandte Chemie International Edition, 2016
- Vector Design Tour de Force: Integrating Combinatorial and Rational Approaches to Derive Novel Adeno-associated Virus VariantsMolecular Therapy, 2014
- Structural Insight into the Unique Properties of Adeno-Associated Virus Serotype 9Journal of Virology, 2012
- PEG conjugation moderately protects adeno‐associated viral vectors against antibody neutralizationBiotechnology and Bioengineering, 2005